Emtricitabine Active Not Recruiting Phase 4 Trials for Pre-Exposure Prophylaxis / Transgender Persons Other

IndicationsStatusPurposePhase
Active Not RecruitingOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT03120936The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community